Dabigatran Etexilate Glenmark Pharmaceuticals Europe

Dabigatran Etexilate Glenmark Pharmaceuticals Europe is an oral medication used to prevent blood clots. It is commonly prescribed for conditions like atrial fibrillation and deep vein thrombosis. This anticoagulant helps reduce the risk of stroke and blood clots in the legs or lungs.

Dabigatran Etexilate is primarily used to prevent blood clots in people with atrial fibrillation, a condition that can lead to irregular heartbeats. It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). What is Dabigatran Etexilate used for? It is often prescribed to reduce the risk of stroke and other complications related to blood clots.

Common effects of Dabigatran Etexilate may include bleeding, bruising, and stomach pain. Some users might experience dizziness or nausea. It is important to monitor for signs of unusual bleeding, as this medication affects blood clotting.

Dabigatran Etexilate should be handled with care, especially if you have a history of bleeding disorders or kidney problems. Always follow the advice of your healthcare provider regarding its use. Keep the medication out of reach of children and store it as directed.

Dabigatran Etexilate may interact with other medications, including blood thinners, NSAIDs, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking. Alcohol consumption should be moderated, as it can increase the risk of bleeding.